Insufficient Data
Stock has not been able to generate better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
—
—
—
Lotus Eye Hospital and Institute Limited is engaged in the provision of healthcare services. The Company is engaged in the field of ophthalmology (eye) and its related operation.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Lotus Eye Hospital and Institute Limited has informed the Exchange regarding 'Reconciliation of Share Capital Audit for the quarter ended 31.12.2022 as per Regulation 76 of the SEBI (DP) Regulation,2018 '. | Download
Lotus Eye Hospital and Institute Limited has informed the Exchange regarding 'Reconciliation of Share Capital Audit for the quarter ended 31.12.2022 as per Regulation 76 of the SEBI (DP) Regulation,2018 '. | Download
Lotus Eye Hospital and Institute Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download
Lotus Eye Hospital and Institute Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download
Final • Div/Share: ₹ 0.5
Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data